American Society of Hirudotherapy

The medicinal leech Hirudo medicinalis: clinical use of the animal and therapeutic prospects of hirudin

Review published in Journal de pharmacie de Belgique (1990)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Narrative reviewClinical LiteratureDrug DevelopmentGenomics & ProteomicsHenriot J et al. · Journal de pharmacie de Belgique, 1990

Abstract

Blood sucking leech, Hirudo medicinalis, used in Medicine for very long, knew an intensive employment during early 18e century but its excess was responsible of the temporary disparition of the animal from the therapeutics. Leech has currently recovered a clinical use, especially in microsurgery. On the other hand, hirudin, main active compound isolated from leech extract and also known and used for long, offers interesting outlooks by its anticoagulant and antithrombic properties. This explains the great interest of hirudin preparation by molecular genetics.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal ArticleReview
Indexed MeSH termsAnimalsGenetic EngineeringHirudin TherapyHirudinsHumansLeechesRecombinant Proteins

Summary

This review describes the renewed clinical use of Hirudo medicinalis, especially in microsurgery, and the anticoagulant and antithrombotic promise of hirudin, the leech's principal active compound, whose preparation by molecular genetics attracts great interest.

Why This Matters for Hirudotherapy

The article discusses the historical and current clinical use of Hirudo medicinalis, noting its intensive employment during the early 18th century, its temporary disappearance from therapeutics due to excessive use, and its modern recovery — particularly in microsurgery. It also addresses the therapeutic prospects of hirudin, described as the main active compound isolated from leech extract with anticoagulant and antithrombotic properties, and the interest in hirudin preparation through molecular genetics. The article links the leech's clinical role to the broader therapeutic potential of one of its key active compounds. The abstract provides a general discussion of established knowledge and future outlooks without presenting detailed experimental data, quantitative outcomes, or specific new findings, limiting its contribution to background and contextual understanding.

Citation

Reference (Vancouver style)

Henriot JM, Chaillot B, Rochette L, Labrude P. [The medicinal leech Hirudo medicinalis: clinical use of the animal and therapeutic prospects of hirudin]. J Pharm Belg. 1990;45(3):207-218. PMID: 2205717

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: March 18, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.